Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy
The most frequent non-thyroidal complication of high-dose (131)I therapy for thyroid carcinoma is salivary gland dysfunction, which may be transient or permanent. In this study, we assessed radioiodine-induced permanent salivary gland dysfunction using quantitative salivary gland scintigraphy. Saliv...
Saved in:
Published in | Nuclear medicine communications Vol. 27; no. 6; p. 495 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
01.06.2006
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The most frequent non-thyroidal complication of high-dose (131)I therapy for thyroid carcinoma is salivary gland dysfunction, which may be transient or permanent. In this study, we assessed radioiodine-induced permanent salivary gland dysfunction using quantitative salivary gland scintigraphy.
Salivary scintigraphy was performed with (99m)Tc-pertechnetate on 50 thyroid carcinoma patients who had been given radioiodine for thyroid ablation; 20 normal subjects were imaged as the control population. Dynamic scintigraphy was performed and time-activity curves for four major salivary glands were generated. The glandular functional parameters maximum secretion, time at maximum count and uptake ratio of the parotid and submandibular glands were calculated. Correlation of the administered dose and subjective symptoms with findings of salivary gland scintigraphy was evaluated.
The maximum secretion and uptake ratio were decreased in 46% and 42% of patients who received radioiodine therapy, respectively. Salivary gland dysfunction correlated well with the administered dose. The parotid glands were more affected than the submandibular glands. Fifty-two per cent of patients were symptomatic, 69.23% of whom showed salivary gland dysfunction.
Parenchymal damage to the salivary glands induced by radioactive iodine treatment can be evaluated by salivary gland scintigraphy. The impairment was worse in parotid glands and increased with the total dose. The maximum secretion and uptake ratio were found to be sufficiently sensitive to distinguish the severity of the damage. |
---|---|
AbstractList | The most frequent non-thyroidal complication of high-dose (131)I therapy for thyroid carcinoma is salivary gland dysfunction, which may be transient or permanent. In this study, we assessed radioiodine-induced permanent salivary gland dysfunction using quantitative salivary gland scintigraphy.
Salivary scintigraphy was performed with (99m)Tc-pertechnetate on 50 thyroid carcinoma patients who had been given radioiodine for thyroid ablation; 20 normal subjects were imaged as the control population. Dynamic scintigraphy was performed and time-activity curves for four major salivary glands were generated. The glandular functional parameters maximum secretion, time at maximum count and uptake ratio of the parotid and submandibular glands were calculated. Correlation of the administered dose and subjective symptoms with findings of salivary gland scintigraphy was evaluated.
The maximum secretion and uptake ratio were decreased in 46% and 42% of patients who received radioiodine therapy, respectively. Salivary gland dysfunction correlated well with the administered dose. The parotid glands were more affected than the submandibular glands. Fifty-two per cent of patients were symptomatic, 69.23% of whom showed salivary gland dysfunction.
Parenchymal damage to the salivary glands induced by radioactive iodine treatment can be evaluated by salivary gland scintigraphy. The impairment was worse in parotid glands and increased with the total dose. The maximum secretion and uptake ratio were found to be sufficiently sensitive to distinguish the severity of the damage. |
Author | Hameed, Abid Raza, Hasan Khan, Aakif U Khan, Ayub |
Author_xml | – sequence: 1 givenname: Hasan surname: Raza fullname: Raza, Hasan email: hrnoor@hotmail.com organization: Atomic Energy Medical Centre, Jinnah Post Graduate Medical Centre, Karachi, Pakistan. hrnoor@hotmail.com – sequence: 2 givenname: Aakif U surname: Khan fullname: Khan, Aakif U – sequence: 3 givenname: Abid surname: Hameed fullname: Hameed, Abid – sequence: 4 givenname: Ayub surname: Khan fullname: Khan, Ayub |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16710103$$D View this record in MEDLINE/PubMed |
BookMark | eNpdT8lOwzAQ9aGILvALyD8QsD2OnRxRxSZVQkhwrqbxuDVKnZJNyt9jtgszh_f0ZnkzSzaLTSTGuBTXUpT2RqQwCmSmEqYUIvuS9IwthNSQgQEzZ8uue09qAcaes7k0VgopYME-XgaMfeixDyNxGrEeEm0ibzzvsA4jthPf1xgdd1Pnh1h9V9H31PIWXWhC40Ik3h-oxdPEhy7E_f_RrgrJZJ8aDtMFO_NYd3T5iyv2dn_3un7MNs8PT-vbTVZBXuis1KihJA3glfUu98qQzi1ZZQuECl25EztwOSmPCiqjLYItlKWiIFKIasWufvaeht2R3PbUhmO6aPv3u_oE1OVgLQ |
CitedBy_id | crossref_primary_10_1016_j_clinimag_2014_12_018 crossref_primary_10_1016_j_joms_2012_09_018 crossref_primary_10_1016_j_jormas_2021_12_014 crossref_primary_10_1155_2022_4651364 crossref_primary_10_1016_j_ultrasmedbio_2015_06_010 crossref_primary_10_1016_j_joms_2020_07_223 crossref_primary_10_1097_MNM_0000000000000820 crossref_primary_10_1007_s12149_013_0735_3 crossref_primary_10_1016_j_ctrv_2015_09_001 crossref_primary_10_1097_MNM_0000000000001161 crossref_primary_10_3390_ijms21114136 crossref_primary_10_1016_j_ijrobp_2007_12_033 crossref_primary_10_1016_j_joms_2017_04_008 crossref_primary_10_1177_1536012120934992 crossref_primary_10_1097_RLU_0000000000002602 crossref_primary_10_2967_jnumed_107_049411 crossref_primary_10_14219_jada_archive_2007_0107 crossref_primary_10_1007_s12285_015_0015_4 crossref_primary_10_1007_s13139_011_0091_y crossref_primary_10_1007_s13139_018_0547_4 crossref_primary_10_3389_fsurg_2022_993712 crossref_primary_10_1186_s13550_021_00770_1 crossref_primary_10_1007_s00247_016_3655_2 crossref_primary_10_2214_AJR_15_15776 crossref_primary_10_1007_s12149_013_0697_5 crossref_primary_10_1089_thy_2019_0563 crossref_primary_10_1097_MNM_0000000000000727 crossref_primary_10_1016_j_ejr_2011_03_007 crossref_primary_10_1097_MNM_0000000000000132 crossref_primary_10_1097_MNM_0000000000000250 crossref_primary_10_1089_ct_2020_32_391_393 crossref_primary_10_1016_S0246_0351_09_51091_4 crossref_primary_10_1097_MNM_0b013e32835ffecd crossref_primary_10_1097_MNM_0b013e328362b1f2 crossref_primary_10_1177_0300891621996817 crossref_primary_10_1007_s13139_014_0274_4 crossref_primary_10_1016_j_ultrasmedbio_2021_05_013 crossref_primary_10_1016_S1639_870X_09_70161_8 crossref_primary_10_2967_jnumed_115_161463 crossref_primary_10_1016_j_joms_2014_09_025 crossref_primary_10_1097_MD_0000000000007164 crossref_primary_10_1016_j_tranon_2022_101445 crossref_primary_10_1016_S1632_3475_09_70291_7 crossref_primary_10_1007_s13139_010_0027_y crossref_primary_10_4158_EP10170_RA crossref_primary_10_1016_j_ultrasmedbio_2016_06_027 crossref_primary_10_1089_thy_2012_0106 crossref_primary_10_1002_hed_26417 crossref_primary_10_3174_ajnr_A3063 crossref_primary_10_23736_S1824_4785_18_03078_9 crossref_primary_10_18632_oncotarget_13395 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1097/00006231-200606000-00004 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 16710103 |
Genre | Controlled Clinical Trial Journal Article |
GroupedDBID | --- .-D .Z2 0R~ 123 4Q1 4Q2 4Q3 53G 5VS 71W 8L- 8WZ A6W AAAAV AAHPQ AAIQE AARTV AASCR AAYEP ABASU ABBUW ABDIG ABJNI ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACILI ACWDW ACWRI ACXJB ACXNZ ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFDTB AFUWQ AGINI AHQNM AHRYX AHVBC AINUH AJIOK AJNWD AJNYG AJZMW ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BQLVK BS7 C45 CAG CGR COF CS3 CUY CVF DIWNM DU5 DUNZO E.X EBS ECM EEVPB EIF EJD EX3 F2K F2L F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IN~ IPNFZ JF9 JG8 JK3 JK8 K8S KD2 KMI L-C N9A NPM N~M O9- OAG OAH OCUKA ODA OL1 OLG OLV OLW OLZ OPUJH ORVUJ OUVQU OVD OVDNE OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RIG RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M WOQ WOW X3V X3W XXN XYM ZFV ZGI ZZMQN |
ID | FETCH-LOGICAL-c3584-94a439e433f27fd5f26e457e7278a3cad9b0b3d5e2fa23c647a37827e88ee2aa2 |
ISSN | 0143-3636 |
IngestDate | Sat Sep 28 08:38:25 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3584-94a439e433f27fd5f26e457e7278a3cad9b0b3d5e2fa23c647a37827e88ee2aa2 |
PMID | 16710103 |
ParticipantIDs | pubmed_primary_16710103 |
PublicationCentury | 2000 |
PublicationDate | 2006-June |
PublicationDateYYYYMMDD | 2006-06-01 |
PublicationDate_xml | – month: 06 year: 2006 text: 2006-June |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Nuclear medicine communications |
PublicationTitleAlternate | Nucl Med Commun |
PublicationYear | 2006 |
SSID | ssj0008367 |
Score | 2.0792367 |
Snippet | The most frequent non-thyroidal complication of high-dose (131)I therapy for thyroid carcinoma is salivary gland dysfunction, which may be transient or... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 495 |
SubjectTerms | Adult Aged Cross-Sectional Studies Female Humans Image Interpretation, Computer-Assisted - methods Iodine Radioisotopes - adverse effects Iodine Radioisotopes - therapeutic use Male Middle Aged Radiation Injuries - diagnostic imaging Radiation Injuries - etiology Radionuclide Imaging Radiopharmaceuticals - adverse effects Radiopharmaceuticals - therapeutic use Recovery of Function - radiation effects Salivary Gland Diseases - diagnostic imaging Salivary Gland Diseases - etiology Salivary Glands - diagnostic imaging Salivary Glands - radiation effects Severity of Illness Index Sodium Pertechnetate Tc 99m Thyroid Neoplasms - complications Thyroid Neoplasms - diagnostic imaging Thyroid Neoplasms - radiotherapy Treatment Outcome |
Title | Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/16710103 |
Volume | 27 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NAFB6qgngR913m4K1E2pnJdiyiFEVBsOBNZkUFW7ce6k_x1_pmSTNExeUSSiZJm7yvb755ee97CB2UXGghWZ4IldOEZVJYDUiRpJ2MlF1CdMeJJJ1fZP0BO71Or1ut9yhrafwqDuXbl3Ul_7Eq7AO72irZP1h2elHYAZ_BvrAFC8P2Vza-HPOhKxKz6T-1brclgC_cvuN5nrRdj462mrzYGSxqC_7M1d3obqQsy_RFWJP22AUOGqfCHAlfEglb31cVu9K2nJi-nbfZ6XWtSZ1Cz98cP-3zKP3n7NbHXXvAX017EIXRtQ--9kSVaR8dPBmLZpCiSqaaxi1pQjOvdVI5Xi8KEAAWe1Hm-25-8u5eNdhNsUBLLRRg-RVK430T48jojw_O6t0MOFTX6Sj8MNrQ3a6GZtBMXljfeWHjQGGOL2jmC_HDbYUcsUoO9KufZ-VpwyUbSxhHZa6W0GJYg-CeB9QyaunhCpo_D3ZcRU8xrnCNKzwyuAIHduDAEa6wwxWOcIUDrrDDVfPUGFdraHByfHXUT0JrjkRSoKxJyTgwWc0oNSQ3KjUk0yzNNbDhglPJVSk6gqpUE8MJlRnLOQUumuui0JpwTtbR7HA01JsIM1vMDIyhWxTgM1QqpClLprQRsJiRorOFNvzDunn0-is31WPc_nZkBy3UKNxFcwb-8HoP2OOr2HeG_ABQqm98 |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitative+evaluation+of+salivary+gland+dysfunction+after+radioiodine+therapy+using+salivary+gland+scintigraphy&rft.jtitle=Nuclear+medicine+communications&rft.au=Raza%2C+Hasan&rft.au=Khan%2C+Aakif+U&rft.au=Hameed%2C+Abid&rft.au=Khan%2C+Ayub&rft.date=2006-06-01&rft.issn=0143-3636&rft.volume=27&rft.issue=6&rft.spage=495&rft_id=info:doi/10.1097%2F00006231-200606000-00004&rft_id=info%3Apmid%2F16710103&rft_id=info%3Apmid%2F16710103&rft.externalDocID=16710103 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3636&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3636&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3636&client=summon |